|
|
|
|
| With a third wave of biologics patents expiring, the race is on to seize the booming opportunities in the fast-evolving biosimilars field. What’s driving the patent scramble? What hurdles in manufacturing, regulation, and market access must be cleared for biosimilars to thrive? And how are global industry leaders carving out strategies to dominate the market? Don’t miss Bioprocess Online Live happening February 4th. Registration is completely free, thanks to the support of Cytiva and Ecolab Life Sciences. |
|
|
|
|
By Ajaz S. Hussain, Ph.D., independent subject matter expert | Addressing systemic cGMP issues requires more than technical fixes — it demands organizational transformation. Thoughtfully applied, AI can empower professionals to become "special agents" of quality, equipped with a "license to care." | |
|
|
|
By Yadnyesh Patel and Vaibhav Patel | Containers and closures, depyrogenation, equipment, materials, personnel, and 7 more major factors all contribute to sterility assurance. | |
|
|
|
|
|
|
|
|
|
|